Kanzymedipharm Inc.

Отрасль

Корма, Пищевые ингредиенты, Промышленная химия

Темы

Корма и кормовые добавки, Аминокислоты и ферментация глутамата натрия, Ферменты и биокатализ, Витамины, каротиноиды и активные вещества нутрицевтиков

Роль

Наука / R&D — “…s and collaborated with the University of Guelph and the University of Montreal [1][2]. The company is private…”

Почему это биоэкономика

Kanzymedipharm Inc. разрабатывает и производит натуральные кормовые добавки и биопрепараты для животноводства.

Как найдена

Blue Ocean Barns; [Rubric] Canada · feed-additives; [Rubric] Canada · methane-feed

Пока не указана поставщиком в решениях с доказательствами.

• 2023 Последний статус: В 2023 г. в отношении компании было опубликовано уведомление о банкротстве, однако на 2026 г. она поддерживает сайт и деловой профиль. ↗ ↗ ↗
• 2026-05-28 Vimy Pharma Files Health Canada Submission for Generic Ozempic® (Semaglutide)
  The press release discusses Vimy Pharma filing a Health Canada Abbreviated New Drug Submission for a generic semaglutide (Ozempic) to boost Canadian pharmaceutical sovereignty, domestic manufacturing, and patient affordability; it does not mention …
• 2026-03-08 Canadian company seeks to stand out with domestically-made generic Ozempic | CBC News
  Vimy Pharma, a new Canadian company formed in 2024, is attempting to launch a Canadian-made generic semaglutide (Ozempic) and run its production at Edmonton’s API facility, highlighting domestic manufacturing and patriotic support for local pharma. This …
• 2026-09-28 KYE Pharma
  Kanzymedipharm Inc. is not mentioned in the provided press release about Kye Pharmaceuticals and AGAMREE (vamorolone) for Duchenne muscular dystrophy. Therefore, the document contains no information about Kanzymedipharm Inc. (one or two sentences).
• 2025-10-20 Diabetes: Canadian firm aims to make generic Ozempic
  Kanzymedipharm Inc. is not mentioned in the provided article; the piece is about Canadian firm Vimy Pharma planning a made-in-Canada generic version of Ozempic (semaglutide). If you meant Vimy Pharma, the takeaway is that they aim to manufacture a …
• 2026-06-04 We're excited to share that we have filed our Submission with Health Canada for Generic Ozempic® (Semaglutide). This filing reflects the incredible work of our Canadian team and strong collaboration with our …
  Kanzymedipharm Inc. is filing a submission with Health Canada for a generic version of Ozempic (semaglutide) through its Canadian team, signaling a push to strengthen domestic pharmaceutical manufacturing and supply resilience. The company emphasizes advancing …
• 2026-07-15 Vimy Pharma Eyes Edmonton-Made Generic Semaglutide Launch | GLP1Prices.ca
  There is no mention of Kanzymedipharm Inc. in the article; it focuses on Vimy Pharma’s plan to file for a generic semaglutide in Canada and potential Edmonton production, with no reference to Kanzymedipharm Inc.

Владельцы и инвесторы 1

Похожие компании

Ralco · Probiotech International Inc. · Bio-Ag Consultants and Distributors · Amlan International · Bio-Vet an Anpario Company · Interbios · Phibro Animal Health · Biofeed Technology Inc.